Provided by Tiger Fintech (Singapore) Pte. Ltd.

ImageneBio, Inc.

17.28
-0.6200-3.46%
Post-market: 17.00-0.2800-1.62%19:53 EDT
Volume:11.73K
Turnover:202.92K
Market Cap:193.22M
PE:-1.67
High:17.90
Open:17.90
Low:17.10
Close:17.90
Loading ...

Director David P. Bonita Reports Acquisition of Common Shares in ImageneBio Inc

Reuters
·
31 Jul

Director Otello Stampacchia Reports Acquisition of Common Shares in ImageneBio Inc

Reuters
·
31 Jul

American Tungsten Advances IMA Mine Rehabilitation and Exploration

TIPRANKS
·
31 Jul

ImageneBio Inc. Files Initial Beneficial Ownership Statement for Erin Butler, Principal Accounting Officer

Reuters
·
30 Jul

ImageneBio Inc. Files Initial Beneficial Ownership Statement for CEO Kristin Yarema

Reuters
·
30 Jul

Ikena Oncology Inc trading halted, news pending

TIPRANKS
·
26 Jul

Ikena Oncology Completes Merger with Inmagene Biopharmaceuticals

TIPRANKS
·
26 Jul

Ikena Oncology Completes 1-for-12 Reverse Stock Split Ahead of Merger

Reuters
·
26 Jul

Ikena Oncology Completes $75 Million Private Placement Amid Merger with Inmagene Biopharmaceuticals

Reuters
·
25 Jul

Inmagene Biopharmaceuticals Announces Completion of Merger With Ikena Oncology and Concurrent Private Placement of $75 Million

THOMSON REUTERS
·
25 Jul

Wedbush Cuts Price Target on Ikena Oncology to $23 From $25, Keeps Neutral Rating

MT Newswires Live
·
25 Jul

Ikena Oncology Q2 EPS $(0.06) Beats $(0.14) Estimate

Benzinga
·
25 Jul

Ikena Oncology Inc. Announces 1-for-12 Reverse Stock Split, Rebrands as ImageneBio, Inc

Reuters
·
24 Jul

Ikena Oncology Inc. and Inmagene Biopharmaceuticals Appoint Kristin Yarema as CEO of Newly Merged ImageneBio

Reuters
·
23 Jul

Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.d., as Chief Executive Officer of Merged Company

THOMSON REUTERS
·
23 Jul

Ikena Oncology Announces Merger with Inmagene

TIPRANKS
·
23 Jul

Ikena Oncology Announces Special Dividend and Contingent Value Rights Following Merger Progress with Inmagene

Reuters
·
23 Jul